Global Health Alerts: Mpox and Syphilis Testing Advances

Recent health news highlights Bavarian Nordic's push for EU approval to extend its mpox vaccine to adolescents, the US FDA's approval of the first at-home syphilis test, and various global measures to combat the mpox virus. Other updates include a polio case in Gaza, rising concerns of Oropouche virus in the Americas, and WHO's efforts for equitable access to medical resources.

Bavarian Nordic seeks EU approval to extend its mpox vaccine to adolescents, a group the WHO identifies as particularly vulnerable. Meanwhile, the US FDA has approved the first at-home syphilis test, which could boost screening rates for the sexually transmitted disease.

The World Health Organization has again declared mpox a global health emergency, highlighting the urgency of global cooperation for equitable access to vaccines. A new mpox case in Europe and Africa's ongoing battle against the disease further emphasize this need.

The Palestinian health ministry reports the first confirmed polio case in Gaza in a 10-month-old who had not been vaccinated. Concurrently, the US CDC warns of a rise in Oropouche virus in the Americas, while WHO officials strategize on preventing COVID-like failures in global health access.

(With inputs from agencies.)